DDI-DrugBank.d687.s0 >> Administration of valproic acid decreases oral clearance of temozolomide by about 5%. >> 18-30,60-71
DDI-DrugBank.d687.s1 >> The clinical implication of this effect is not known.
DDI-DrugBank.d687.s2 >> Patients with Severe Hepatic or Renal Impairment Caution should be exercised when TEMODAR Capsules are administered to patients with severe hepatic or renal impairment. >> 82-88
